PT1128809E - Formulacoes oftalmicas aquosas comprendendo quitosano - Google Patents

Formulacoes oftalmicas aquosas comprendendo quitosano

Info

Publication number
PT1128809E
PT1128809E PT98954658T PT98954658T PT1128809E PT 1128809 E PT1128809 E PT 1128809E PT 98954658 T PT98954658 T PT 98954658T PT 98954658 T PT98954658 T PT 98954658T PT 1128809 E PT1128809 E PT 1128809E
Authority
PT
Portugal
Prior art keywords
chitosan
ophthalmic formulation
ofthalmal
formulacs
aquosal
Prior art date
Application number
PT98954658T
Other languages
English (en)
Inventor
Robert Gurny
Felt Olivia
Original Assignee
Medidom Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medidom Lab filed Critical Medidom Lab
Publication of PT1128809E publication Critical patent/PT1128809E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Cosmetics (AREA)
PT98954658T 1998-11-20 1998-11-20 Formulacoes oftalmicas aquosas comprendendo quitosano PT1128809E (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98954658A EP1128809B1 (en) 1998-11-20 1998-11-20 Aqueous ophthalmic formulations comprising chitosan
PCT/IB1998/001886 WO2000030609A1 (en) 1998-11-20 1998-11-20 Aqueous ophthalmic formulations comprising chitosan

Publications (1)

Publication Number Publication Date
PT1128809E true PT1128809E (pt) 2005-04-29

Family

ID=11004783

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98954658T PT1128809E (pt) 1998-11-20 1998-11-20 Formulacoes oftalmicas aquosas comprendendo quitosano

Country Status (9)

Country Link
EP (1) EP1128809B1 (pt)
AT (1) ATE285751T1 (pt)
AU (1) AU1169999A (pt)
DE (1) DE69828451T2 (pt)
DK (1) DK1128809T3 (pt)
ES (1) ES2234164T3 (pt)
PT (1) PT1128809E (pt)
SI (1) SI1128809T1 (pt)
WO (1) WO2000030609A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6716970B2 (en) 2000-04-21 2004-04-06 Adjuvant Pharmaceuticals, Llc Water soluble, randomly substituted partial N-partial O-acetylated chitosan, preserving compositions containing chitosan, and processes for making thereof
US20020018732A1 (en) * 2000-04-21 2002-02-14 Hung William M. Preserving compositions containing chitosan and processes for making water soluble O-acetylated chitosan and chitosan
PT1157688E (pt) * 2000-05-26 2003-08-29 Medidom Lab Formulacoes oftalmicas aquosas antibacterianas contendo ofloxacina e quitosano
US20020119949A1 (en) * 2001-02-26 2002-08-29 Asa Hellman Prophylactic teat treatment
US7125967B2 (en) 2003-10-08 2006-10-24 Adjuvant Pharmaceuticals, Llc Water-soluble chitosan having low endotoxin concentration and methods for making and using the same
WO2007002345A2 (en) * 2005-06-21 2007-01-04 Bausch & Lomb Incorporated Method for improving water solubility of chitosan
US20170128481A9 (en) * 2009-03-06 2017-05-11 Insite Vision Corporation Ocular treatment with reduced intraocular pressure
EP2555760B1 (en) * 2010-04-06 2019-10-16 Synedgen, Inc. Chitosan derivatives for the treatment of mucositis or ulceration
US10022393B2 (en) 2012-09-20 2018-07-17 Synedgen, Inc. Methods for treatment or prevention of damage resulting from radiation, trauma or shock
WO2016066195A1 (en) * 2014-10-29 2016-05-06 Laboratoire Medidom Sa Heat-sterilized formulation comprising chitosan and process of preparation thereof
EP3471742A4 (en) * 2016-06-16 2020-03-04 Eye Care International, LLC COMPOSITIONS AND METHODS FOR TREATING DRY EYE AND OTHER TRAUMATIZED NON-KERATINIZED EPITHELIAL SURFACES

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4956350A (en) * 1988-08-18 1990-09-11 Minnesota Mining And Manufacturing Company Wound filling compositions
CH675535A5 (pt) * 1988-11-28 1990-10-15 Nestle Sa
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system

Also Published As

Publication number Publication date
DE69828451T2 (de) 2006-01-12
EP1128809B1 (en) 2004-12-29
AU1169999A (en) 2000-06-13
WO2000030609A1 (en) 2000-06-02
DE69828451D1 (de) 2005-02-03
SI1128809T1 (en) 2005-06-30
DK1128809T3 (da) 2005-04-25
ES2234164T3 (es) 2005-06-16
EP1128809A1 (en) 2001-09-05
ATE285751T1 (de) 2005-01-15

Similar Documents

Publication Publication Date Title
WO2004062589A3 (en) An emollient alcohol skin disinfecting formulation
WO2008011836A3 (es) Soluciones oftálmicas
US20100316739A1 (en) Chitosan gel for dermatological use, production method therefor and use of same
PT1128809E (pt) Formulacoes oftalmicas aquosas comprendendo quitosano
ATE546135T1 (de) Hyaluronsäure-nanopartikel
BR0013010B1 (pt) Formulação aquosa de cloreto de sódio de moxifloxacina, processo para sua preparação e aplicação da referida formulação, bem como preparado de combinação e aplicação de uma solução aquosa de cloridrato de moxifloxacina
RU93056633A (ru) Антиаллергическая композиция для лечения глаз или носа
MY130477A (en) Pharmaceutical compositions for the treatmen of mucositis, stomatitis and behcet,s syndrome
DK0801948T3 (da) Oftalmisk sammensætning med forlænget opholdstid i øjet
AU1865100A (en) Hyaluronate lyase used for promoting penetration in topical agents
BR9804875A (pt) Uso de uma composição e peocesso para tratamento profilático ou de cicatrização de feridas de animais de lactação.
CA2345466A1 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
CA2519797A1 (en) Low molecular weight hyaluronic acid for the treatment of nerve damage
ES2125696T3 (es) Utilizacion del cloruro de tropsio para la produccion de una preparacion farmaceutica para el tratamiento de disfunciones vesicales.
DK0594770T3 (da) Oftalmologiske blandinger
ATE238767T1 (de) Antibakterielle wässerige ophtalmische formulierungen mit ofloxacin und chitosan
CA2413088C (en) Preservative
DE69941459D1 (de) Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
AU727844B2 (en) Brine treatment
ATE158719T1 (de) Verwendung von hexetidin oder dessen derivaten oder salzen zur herstellung einer pharmazeutischen zusammensetzung für ophthalmische verwendung
WO2007033020A3 (en) Ophthalmic formulation for treatment of dry eye
KR960037046A (ko) 도파민 수용기 자극제를 포함하는 근시 및 녹내장 치료용 안과 제형